Achieve Life Sciences, Inc. QUIT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 81.08% | 96.15% | 76.27% | 96.17% | 90.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.51% | 16.29% | 14.07% | 40.47% | 67.40% |
| Operating Income | -22.51% | -16.29% | -14.07% | -40.47% | -67.40% |
| Income Before Tax | -113.41% | -126.19% | -12.63% | -37.21% | -58.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -113.41% | -126.19% | -12.63% | -37.21% | -58.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.41% | -126.19% | -12.63% | -37.21% | -58.90% |
| EBIT | -22.51% | -16.29% | -14.07% | -40.47% | -67.40% |
| EBITDA | -22.61% | -16.38% | -14.16% | -40.71% | -67.90% |
| EPS Basic | -0.17% | -6.14% | 16.67% | -5.43% | -22.06% |
| Normalized Basic EPS | -1.83% | -8.27% | 15.07% | -6.98% | -24.52% |
| EPS Diluted | -0.17% | -6.14% | 16.67% | -5.43% | -22.06% |
| Normalized Diluted EPS | -1.83% | -8.27% | 15.07% | -6.98% | -24.52% |
| Average Basic Shares Outstanding | 97.32% | 81.71% | 39.52% | 35.43% | 34.83% |
| Average Diluted Shares Outstanding | 97.32% | 81.71% | 39.52% | 35.43% | 34.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |